Clotting Propensity of Surface-Treated Membranes in a Hemodialysis Set-up That Avoids Systemic Anticoagulation

Hideki Kawanishi, Masahide Koremoto, Casper F M Franssen*, Marco van Londen

*Corresponding author voor dit werk

Onderzoeksoutputpeer review

1 Citaat (Scopus)
1 Downloads (Pure)

Samenvatting

The development of biocompatible membranes, aiming to limit the inflammatory response, oxidative stress, and coagulability during hemodialysis, has been an important step in reducing dialysis-related adverse outcomes. This includes a reduction in the risk of clotting of the extracorporeal circuit, thus enabling hemodialysis with a reduced dose or even without systemic anticoagulant drugs in patients with an increased bleeding risk. In this article, we summarize the in vitro research and clinical evidence on the antithrombotic properties of vitamin E- and heparin-coated membranes.

Originele taal-2English
Artikelnummer151482
Aantal pagina's10
TijdschriftSeminars in Nephrology
Volume43
Nummer van het tijdschrift6
DOI's
StatusPublished - 1-nov.-2023

Vingerafdruk

Duik in de onderzoeksthema's van 'Clotting Propensity of Surface-Treated Membranes in a Hemodialysis Set-up That Avoids Systemic Anticoagulation'. Samen vormen ze een unieke vingerafdruk.

Citeer dit